|
ALT levels (U/L)
|
Hypertensive, n (%)
|
Age-adjusted OR (95% CI)
|
Model I
|
Model II
|
|---|
| | | |
Multi-adjusted OR (95% CI)
|
Multi-adjusted OR (95% CI)
|
|---|
|
Group I
| | | | |
|
0–40
|
257,764 (2.48)
|
1
|
1
|
1
|
|
40.01–
|
27,691 (4.64)
|
1.91 (1.88,1.93)
|
1.56 (1.54,1.58)
|
1.52 (1.50,1.54)
|
|
Group II
| | | | |
|
0–20
|
162,779 (2.27)
|
1
|
1
|
1
|
|
20.01–40
|
94,985 (2.93)
|
1.27 (1.26,1.28)
|
1.17 (1.16,1.18)
|
1.17 (1.16,1.18)
|
|
40.01–60
|
15,838 (4.45)
|
1.94 (1.91,1.97)
|
1.59 (1.57,1.62)
|
1.56 (1.53,1.58)
|
|
60.01–80
|
5730 (4.62)
|
2.08 (2.02,2.14)
|
1.64 (1.60,1.69)
|
1.59 (1.55,1.64)
|
|
80.01–
|
6123 (5.22)
|
2.46 (2.40,2.53)
|
1.87 (1.82,1.93)
|
1.79 (1.74,1.84)
|
|
P for trend†
| |
< 0.001
|
< 0.001
|
< 0.001
|
- ALT: alanine aminotransferase; OR: odds ratios; CI: confidence interval
- Model I: Adjusted for age, sex, ethnicity, area, education, body mass index, average salt consumption, history of diabetes, overall pressure and hepatitis B surface antigen status
- Model II: add fasting blood glucose concentration as a new covariate based on Model I
- †P for trend were calculated by setting categorized ALT levels as a continuous variable
